NCT01863511View on ClinicalTrials.gov

Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Decompensated Heart Failure
Interventions
DRUG

loop diuretic

DRUG

tolvaptan

PROCEDURE

ultrafiltration

Trial Locations (1)

45011

The Christ Hospital, Cincinnati

All Listed Sponsors
lead

The Christ Hospital

OTHER

NCT01863511 - Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure | Biotech Hunter | Biotech Hunter